Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mendenhall

Showing results (561-570 of 660) with videos related to

Pageof 66
Sort By:
Journal of Neuro-Oncology|March 4, 2019
Proton therapy for skull-base chondrosarcoma, a single-institution outcomes studyAdam L Holtzman, Ronny L Rotondo, Michael S Rutenberg, et al.
Advances in Radiation Oncology|September 11, 2018
Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinomaGreg D Judy, Rebecca Green, Shannon L Aumer, et al.
Head & Neck|July 6, 2013
Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based reviewVinidh Paleri, Justin W G Roe, Primož Strojan, et al.
Cancer|July 1, 1990
Prophylactic glutamine protects the intestinal mucosa from radiation injuryV S Klimberg, W W Souba, D J Dolson, et al.
Pediatric Blood & Cancer|November 29, 2023
Outcomes following proton therapy for pediatric esthesioneuroblastomaNicolette R Drescher, Daniel J Indelicato, Roi Dagan, et al.
Head & Neck|May 1, 1995
Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neckM P McLaughlin, W M Mendenhall, A A Mancuso, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapySin Ming Chow, Stephen C K Law, William M Mendenhall, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.
International Journal of Particle Therapy|November 28, 2019
Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton TherapyCurtis Bryant, Bradford S Hoppe, Randal H Henderson, et al.
Oral Oncology|June 18, 2016
Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of lifeKyle Wang, Robert J Amdur, William M Mendenhall, et al.
Pageof 66

Showing results (561-570 of 660) with videos related to

Sort By:
Pageof 66
Journal of Neuro-Oncology|March 4, 2019
Proton therapy for skull-base chondrosarcoma, a single-institution outcomes studyAdam L Holtzman, Ronny L Rotondo, Michael S Rutenberg, et al.
Advances in Radiation Oncology|September 11, 2018
Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinomaGreg D Judy, Rebecca Green, Shannon L Aumer, et al.
Head & Neck|July 6, 2013
Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based reviewVinidh Paleri, Justin W G Roe, Primož Strojan, et al.
Cancer|July 1, 1990
Prophylactic glutamine protects the intestinal mucosa from radiation injuryV S Klimberg, W W Souba, D J Dolson, et al.
Pediatric Blood & Cancer|November 29, 2023
Outcomes following proton therapy for pediatric esthesioneuroblastomaNicolette R Drescher, Daniel J Indelicato, Roi Dagan, et al.
Head & Neck|May 1, 1995
Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neckM P McLaughlin, W M Mendenhall, A A Mancuso, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapySin Ming Chow, Stephen C K Law, William M Mendenhall, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.
International Journal of Particle Therapy|November 28, 2019
Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton TherapyCurtis Bryant, Bradford S Hoppe, Randal H Henderson, et al.
Oral Oncology|June 18, 2016
Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of lifeKyle Wang, Robert J Amdur, William M Mendenhall, et al.
Pageof 66